We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current ACRV market cap is 180.56M. The company's latest EPS is USD -1.9395 and P/E is -2.96.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -16.14M | -21.05M | -17.67M | -21.44M | -25.14M |
| Net Income | -14.47M | -19.25M | -16.49M | -18.8M | -22.44M |
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 |
| Operating Income | -16.18M | -32.66M | -67.1M |
| Net Income | -16.24M | -31.17M | -60.39M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Assets | 151.09M | 138.27M | 120.52M | 230.59M | 214.68M |
| Total Liabilities | 12.94M | 17.07M | 12.54M | 14.53M | 17.79M |
| Total Equity | 138.15M | 121.2M | 107.98M | 216.06M | 196.89M |
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 106.59M | 181.23M | 138.27M |
| Total Liabilities | 7.88M | 10.75M | 17.07M |
| Total Equity | -23.81M | 170.48M | 121.2M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Operating | -30.28M | -42.64M | -17.08M | -30.99M | -48.31M |
| Investing | 30.18M | 50.72M | 5.85M | -82.19M | -66.18M |
| Financing | 457k | -1.55M | -172k | 123.18M | 121.67M |
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Operating | -13.98M | -30.12M | -42.64M |
| Investing | -238k | -141.68M | 50.72M |
| Financing | 112.22M | 101.71M | -1.55M |
| Market Cap | 180.56M |
| Price to Earnings Ratio | -2.96 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 4.96 |
| Price to Book Ratio | 1.47 |
| Dividend Yield | - |
| Shares Outstanding | 31.14M |
| Average Volume (1 week) | 39.77k |
| Average Volume (1 Month) | 49.72k |
| 52 Week Change | 31.80% |
| 52 Week High | 11.90 |
| 52 Week Low | 3.19 |
| Spread (Intraday) | 0.19 (3.28%) |
| Company Name | Acrivon Therapeutics Inc |
| Address |
838 walker road dover, delaware 19904 |
| Website | https://www.acrivon.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
